Phase I clinical trial of continuous infusion cyclopentenyl cytosine

Cancer Chemotherapy and Pharmacology ◽

10.1007/bf00685802 ◽

1995 ◽

Vol 36 (6) ◽

pp. 513-523 ◽

Author(s):

Pedro M. Politi ◽

Fuming Xie ◽

William Dahut ◽

Harry Ford ◽

James A. Kelley ◽

...

Keyword(s):

Clinical Trial ◽

Phase I ◽

Continuous Infusion ◽

Phase I Clinical Trial ◽

Cyclopentenyl Cytosine

Download Full-text

Phase I clinical trial of continuous infusion cyclopentenyl cytosine

Cancer Chemotherapy and Pharmacology ◽

10.1007/s002800050357 ◽

1995 ◽

Vol 36 (6) ◽

pp. 513-523 ◽

Author(s):

P. M. Politi ◽

F. Xie ◽

William Dahut ◽

Harry Ford Jr. ◽

James A. Kelley ◽

...

Keyword(s):

Clinical Trial ◽

Phase I ◽

Continuous Infusion ◽

Phase I Clinical Trial ◽

Cyclopentenyl Cytosine

Download Full-text

Abstract 5585: Phase I clinical trial of continuous infusion of tyroserleutide in patients with advanced hepatocellular carcinoma

10.1158/1538-7445.am2012-5585 ◽

2012 ◽

Author(s):

Jia Jinbin ◽

Xiao Zhen-Yu ◽

Chen Xiao-Ping

Keyword(s):

Hepatocellular Carcinoma ◽

Clinical Trial ◽

Phase I ◽

Continuous Infusion ◽

Phase I Clinical Trial ◽

Advanced Hepatocellular Carcinoma

Download Full-text

Phase I clinical trial of continuous infusion of tyroserleutide in patients with advanced hepatocellular carcinoma

Medical Oncology ◽

10.1007/s12032-011-0081-z ◽

2011 ◽

Vol 29 (3) ◽

pp. 1850-1858 ◽

Author(s):

Zhen-Yu Xiao ◽

Jin-Bin Jia ◽

Lin Chen ◽

Wei Zou ◽

Xiao-Ping Chen

Keyword(s):

Hepatocellular Carcinoma ◽

Clinical Trial ◽

Phase I ◽

Continuous Infusion ◽

Phase I Clinical Trial ◽

Advanced Hepatocellular Carcinoma

Download Full-text

SP-0598: Cilengitide in continuous infusion with radio-chemotherapy in stage III NSCLC: A phase I clinical trial

Radiotherapy and Oncology ◽

10.1016/s0167-8140(15)40592-4 ◽

2015 ◽

Vol 115 ◽

pp. S291

Author(s):

E. Cohen-Jonathan Moyal ◽

C. Massabeau ◽

T. Filleron ◽

A. Modesto ◽

J.M. Bachaud ◽

...

Keyword(s):

Clinical Trial ◽

Phase I ◽

Continuous Infusion ◽

Phase I Clinical Trial ◽

Stage Iii ◽

Stage Iii Nsclc ◽

Radio Chemotherapy

Download Full-text

A PHASE-I CLINICAL-TRIAL OF A PROTRACTED CONTINUOUS-INFUSION OF 5-FLUOROURACIL WITH ORAL FOLINIC ACID IN PATIENTS WITH UNRESECTABLE ADENOCARCINOMA OF THE COLON OR RECTUM

International Journal of Oncology ◽

10.3892/ijo.7.1.191 ◽

1995 ◽

Author(s):

DV JONES ◽

KR DAUGHERTY ◽

JL ABBRUZZESE

Keyword(s):

Clinical Trial ◽

Phase I ◽

Continuous Infusion ◽

Folinic Acid ◽

Phase I Clinical Trial ◽

Adenocarcinoma Of The Colon

Download Full-text

Phase I Clinical Trial of a Genetically Modified and Oncolytic Vaccinia Virus GL-ONC1 in patients with peritoneal carcinomatosis

Zeitschrift für Gastroenterologie ◽

10.1055/s-0032-1324086 ◽

2012 ◽

Vol 50 (08) ◽

Author(s):

UM Lauer ◽

M Zimmermann ◽

U Koppenhöfer ◽

M Bitzer ◽

NP Malek ◽

...

Keyword(s):

Clinical Trial ◽

Phase I ◽

Vaccinia Virus ◽

Peritoneal Carcinomatosis ◽

Genetically Modified ◽

Phase I Clinical Trial

Download Full-text

SAFETY OF A NEW CUBAN PNEUMOCOCCAL CONJUGATE VACCINE: A PHASE I CLINICAL TRIAL IN INFANTS 7 MONTH-OLD

10.26226/morressier.5731f0d7d462b8029237fd99 ◽

2016 ◽

Author(s):

Rinaldo Puga-Gomez

Keyword(s):

Clinical Trial ◽

Phase I ◽

Conjugate Vaccine ◽

Pneumococcal Conjugate Vaccine ◽

Phase I Clinical Trial

Download Full-text

Faculty Opinions recommendation of Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1118816.793494158 ◽

2014 ◽

Author(s):

Thomas Flaig

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Phase I ◽

Abiraterone Acetate ◽

Selective Inhibitor ◽

Phase I Clinical Trial ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Faculty Opinions recommendation of A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718026292.793481389 ◽

2013 ◽

Author(s):

Steve Plaxe ◽

Kristy Ward

Keyword(s):

Ovarian Cancer ◽

Clinical Trial ◽

Phase I ◽

Recurrent Ovarian Cancer ◽

Phase I Clinical Trial ◽

Conditionally Replicative Adenovirus

Download Full-text

Faculty Opinions recommendation of GTL001, A Therapeutic Vaccine for Women Infected with Human Papillomavirus 16 or 18 and Normal Cervical Cytology: Results of a Phase I Clinical Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726394953.793529283 ◽

2017 ◽

Author(s):

Lucy Dorrell

Keyword(s):

Clinical Trial ◽

Human Papillomavirus ◽

Phase I ◽

Therapeutic Vaccine ◽

Phase I Clinical Trial ◽

Cervical Cytology ◽

Human Papillomavirus 16 ◽

Normal Cervical Cytology

Download Full-text